Life Sciences Tools & Services (16) | Severance Agreements (16)
Browse by Company
Recent Contracts
-
Akoya Biosciences, Inc. Executive Severance Plan
(Akoya Biosciences, Inc., Filed With SEC on March 29, 2022)
-
Science 37 Holdings, Inc. Executive Severance Policy
(Lifesci Acquisition II Corp., Filed With SEC on March 22, 2022)
-
Amended and Restated Executive Severance Agreement, by and between Dr. Richard Chen and the Registrant, dated February 23, 2022
(Personalis, Inc., Filed With SEC on February 24, 2022)
-
Amended and Restated Executive Severance Agreement, by and between John West and the Registrant, dated February 23, 2022
(Personalis, Inc., Filed With SEC on February 24, 2022)
-
Amended and Restated Executive Severance Agreement, by and between Aaron Tachibana and the Registrant, dated February 23, 2022
(Personalis, Inc., Filed With SEC on February 24, 2022)
-
Cytek Biosciences, Inc. Amended and Restated Severance Benefit Plan
(Cytek BioSciences, Inc., Filed With SEC on July 19, 2021)
-
Quantum-Si Incorporated Executive Severance Plan
(HighCape Capital Acquisition Corp., Filed With SEC on July 6, 2021)
-
Executive Severance Plan
(Singular Genomics Systems, Inc., Filed With SEC on May 24, 2021)
-
Severance Agreement, dated September 1, 2020, between SomaLogic, Inc. and Lawrence Gold
(CM Life Sciences II Inc., Filed With SEC on May 14, 2021)
-
First Amendment to Severance Agreement, dated December 4, 2020, between SomaLogic, Inc. and Lawrence Gold
(CM Life Sciences II Inc., Filed With SEC on May 14, 2021)
